Biosensors are analytical tools using biological specificity to sense the target molecule. The biosensor technology is used for the detection of various human health-related conditions such as cardiovascular disease, cancer, diabetes and infectious diseases. Advances in scientific disciplines that include genetics, medicine, bioinformatics, etc., fueled the discovery of new biomarkers. Many diagnostic tests (noninvasive/minimally invasive) for the early detection of cancer biomarkers are available on the market. This is a huge market compared to the markets covered for Food and Beverages, Environment safety, Defense and security and other areas pertaining to molecular biosensors applications.
Molecular biosensor market benefits investors, clinical laboratories, hospitals, pharmaceutical companies, biotechnology companies, chemical sensor companies, contract research organizations, environment safety agencies and health regulatory authorities.
The market for molecular biosensors is segmented on basis of Application (Medical diagnostics, pharma & biotech, Food and Beverages, Environment safety, Defense and security and others), Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors and Peizoelectric Biosensors), Type (Biological Signaling, Transduction element and Recognition element) and Geographical Regions.
Geographically, North America has the largest share in global molecular biosensors market, followed by Europe. While Asia-Pacific also has emerged as the fastest growing region in this market.
Some of the major competitors include Siemens Healthcare, LifeSensors, Inc., Nova biomedical Corporation, Abbott Laboratories, Inc., Johnson and Johnson, Medtronic, Inc., F. Hoffmann La Roche, and Bayer AG
Increasing prevalence of chronic and lifestyle induced diseases, Increasing diabetic population, increasing demand for Point of Care Testing (POCT), rise in geriatric population and increasing application of biosensors in various industries are major factors driving the growth of this market.
Strict regulatory requirements for biosensors and Reimbursement policies issues in healthcare systems are major constraints for the growth of biosensors market.
Key Deliverables in the Study?
1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.
2) Market analysis for the Global Molecular Biosensors Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.
3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
5)Identification and analysis of the Macro and Micro factors that affect the Global Molecular Biosensors Market in Healthcare Industry on both global and regional scale.
6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Applications of Molecular Biosensors
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value-Chain Analysis
5.6 Product Life-Cycle Analysis
5.7 Product Benchmarking
5.8 Investment Analysis
5.8 Porter’s Five Forces
5.8.1 Bargaining Power of Suppliers
5.8.2 Bargaining Power of Consumers
5.8.3 Threat of New Entrants
5.8.4 Threat of Substitute Products and Services
5.8.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing prevalence of chronic and lifestyle induced diseases
6.1.2 Increasing demand for Point of Care Testing
6.1.3 Increasing application of biosensors in various industries
6.2 Market Restraints
6.2.1 Strict regulatory requirements for biosensors
6.2.2 Reimbursement policies issues in healthcare systems
6.3 Key Challenges
6.4 Current Opportunities in the Market
7. Market Segmentation
7.1 By Application
7.1.1 Medical diagnostics
7.1.2 Pharma & biotech
7.1.3 Food and Beverages
7.1.4 Environment safety
7.1.5 Defense and security
7.2 By Technology
7.2.1 Electrochemical Biosensors
7.2.2 Optical Biosensors
7.2.3 Thermal Biosensors
7.2.4 Peizoelectric Biosensors
7.3 By Type
7.3.1 Biological Signaling
7.3.2 Transduction element
7.3.3 Recognition element
7.4 By Geography
7.4.1 North America
184.108.40.206 Rest of North America
220.127.116.11 Rest of Europe
18.104.22.168 Soth Korea
22.214.171.124 Rest of Asia Pacific
7.4.4 Middle-East and Africa (MEA)
126.96.36.199 Saudi Arabia
188.8.131.52 Rest of the MEA
7.4.5 Latin America
184.108.40.206 Rest of Latin America
8. Competitive Landscape
8.1 Merger and Acquisition Analysis
8.2 Patent Analysis
8.3 The Challengers
9. Company Profiles
9.1 Siemens Healthcare
9.2 LifeSensors, Inc.
9.3 Nova biomedical Corporation
9.4 Abbott Laboratories, Inc.
9.5 Johnson and Johnson
9.6 Medtronic, Inc.
9.7 F. Hoffmann La Roche
9.8 Bayer AG
10. Analyst Outlook for Investment Opportunities
11. Future Outlook of the Market